Brief: FDA Grants Accelerated Approval For Padcev With Keytruda For First-Line Treatment Of Locally Advanced Or Metastatic Urothelial Cancer
03/04/2023 22:03
April 3 (Reuters) - Seagen Inc SGEN.O :
* FDA GRANTS ACCELERATED APPROVAL FOR PADCEV WITH KEYTRUDA
FOR
FIRST-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC
UROTHELIAL CANCER
Source text for Eikon: ID:nBw7gV38Sa
Further company coverage: SGEN.O
((Reuters.Briefs@thomsonreuters.com;))